Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

Wednesday’s trading has closed, but HALO is being traded in the after-hours session. After-Hours quote »
Delayed Data
As of 4:00pm ET
 +0.17 / +0.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 25.00, with a high estimate of 28.00 and a low estimate of 7.00. The median estimate represents a +41.64% increase from the last price of 17.65.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.19%
Growthannually 25.28%


Growthquarterly 31.94%
Growthannually 46.37%
Key to the earnings and sales forecast charts.